Cargando…
The Structural Understanding of Transthyretin Misfolding and the Inspired Drug Approaches for the Treatment of Heart Failure Associated With Transthyretin Amyloidosis
Substantial controversies exist in the exploration of the molecular mechanism of heart failure (HF) and pose challenges to the diagnosis of HF and the discovery of specific drugs for the treatment. Recently, cardiac transthyretin (TTR) amyloidosis is becoming recognized as one of major causes of und...
Autores principales: | He, Shan, He, Xinyue, Liu, Lei, Zhang, Wenbo, Yu, Lanlan, Deng, Zhun, Feiyi, Zhang, Mo, Shanshan, Fan, Yue, Zhao, Xinyue, Wang, Lun, Wang, Chenxuan, Zhang, Shuyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7930814/ https://www.ncbi.nlm.nih.gov/pubmed/33679409 http://dx.doi.org/10.3389/fphar.2021.628184 |
Ejemplares similares
-
Clinical phenotypes and genetic features of hereditary transthyretin amyloidosis patients in China
por: He, Xinyue, et al.
Publicado: (2022) -
A Brief Journey through Protein Misfolding in Transthyretin Amyloidosis (ATTR Amyloidosis)
por: Gonzalez-Duarte, Alejandra, et al.
Publicado: (2021) -
Transthyretin cardiac amyloidosis
por: Tomoaia, Raluca, et al.
Publicado: (2021) -
Transthyretin cardiac amyloidosis
por: Porcari, Aldostefano, et al.
Publicado: (2022) -
EGCG-Mediated Protection of Transthyretin Amyloidosis by Stabilizing Transthyretin Tetramers and Disrupting Transthyretin Aggregates
por: Zou, Huizhen, et al.
Publicado: (2023)